Free Trial

Ucommune International (UK) Competitors

Ucommune International logo
$1.04 +0.06 (+6.12%)
Closing price 03:57 PM Eastern
Extended Trading
$1.03 -0.01 (-0.48%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UK vs. ISPC, TC, LICN, VCIG, APDN, AUUD, HAO, SYRA, CAUD, and NHIQ

Should you be buying Ucommune International stock or one of its competitors? The main competitors of Ucommune International include iSpecimen (ISPC), Token Cat (TC), Lichen International (LICN), VCI Global (VCIG), Applied DNA Sciences (APDN), Auddia (AUUD), Haoxi Health Technology (HAO), Syra Health (SYRA), Collective Audience (CAUD), and NantHealth (NHIQ). These companies are all part of the "business services" industry.

Ucommune International vs. Its Competitors

Ucommune International (NASDAQ:UK) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Ucommune International has a net margin of 0.00% compared to iSpecimen's net margin of -139.63%. Ucommune International's return on equity of 0.00% beat iSpecimen's return on equity.

Company Net Margins Return on Equity Return on Assets
Ucommune InternationalN/A N/A N/A
iSpecimen -139.63%-285.20%-114.37%

36.9% of Ucommune International shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 14.2% of Ucommune International shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Ucommune International has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.

Ucommune International has higher revenue and earnings than iSpecimen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ucommune International$23.92M0.03-$9.49MN/AN/A
iSpecimen$9.29M0.29-$12.50M-$12.89-0.08

In the previous week, iSpecimen had 3 more articles in the media than Ucommune International. MarketBeat recorded 4 mentions for iSpecimen and 1 mentions for Ucommune International. Ucommune International's average media sentiment score of 1.87 beat iSpecimen's score of 0.94 indicating that Ucommune International is being referred to more favorably in the media.

Company Overall Sentiment
Ucommune International Very Positive
iSpecimen Positive

Summary

Ucommune International beats iSpecimen on 8 of the 11 factors compared between the two stocks.

Get Ucommune International News Delivered to You Automatically

Sign up to receive the latest news and ratings for UK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UK vs. The Competition

MetricUcommune InternationalREAL ESTATE OPS IndustryFinance SectorNASDAQ Exchange
Market Cap$610K$6.42B$12.29B$9.51B
Dividend YieldN/A4.47%5.55%4.01%
P/E RatioN/A32.1419.0320.05
Price / Sales0.036.6426.0199.42
Price / CashN/A21.9421.6358.56
Price / Book0.031.922.205.87
Net Income-$9.49M$110.99M$997.25M$258.55M
7 Day Performance2.02%1.76%0.89%2.23%
1 Month Performance-4.06%6.76%4.37%12.76%
1 Year Performance-46.11%18.59%540.78%19.36%

Ucommune International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UK
Ucommune International
1.9432 of 5 stars
$1.04
+6.1%
N/A-49.6%$610K$23.92M0.00510Positive News
Upcoming Earnings
ISPC
iSpecimen
0.6038 of 5 stars
$1.07
-1.4%
N/A+300.0%$2.66M$8.06M-0.0860News Coverage
Positive News
Gap Up
TC
Token Cat
N/A$0.80
-1.7%
N/A-57.1%$2.54M$6.74M0.00620Gap Down
LICN
Lichen International
N/A$4.22
-0.6%
N/A-99.0%$2.53M$41.48M0.00390Positive News
Gap Up
VCIG
VCI Global
0.1251 of 5 stars
$1.15
-0.4%
N/A-99.8%$2.41M$124.39M0.00102High Trading Volume
APDN
Applied DNA Sciences
0.7882 of 5 stars
$5.15
-1.8%
N/A-98.3%$2.26M$3.43M-0.0170Gap Down
AUUD
Auddia
0.5454 of 5 stars
$4.13
-1.1%
N/A-78.9%$2.10MN/A-0.1020
HAO
Haoxi Health Technology
N/A$1.40
+0.3%
N/A-98.7%$1.81M$48.97M0.0029Positive News
SYRA
Syra Health
0.1437 of 5 stars
$0.07
-7.2%
N/A-91.7%$799K$7.98M-0.1178Gap Up
CAUD
Collective Audience
N/A$0.03
-1.6%
N/A-89.6%$737K$12.14M0.0023
NHIQ
NantHealth
N/A$0.01
+18.2%
N/AN/A$424K$67M0.00340Gap Up

Related Companies and Tools


This page (NASDAQ:UK) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners